Zdrowie i gospodarka · 21/07/2003

FDA Approves New Meloxicam Oral Suspension for Dogs with Osteoarthritis

The US Food and Drug Administration (FDA) has amended its animal drug regulations to approve a new application by Boehringer Ingelheim Vetmedica, Inc. for the use of meloxicam oral suspension to treat pain and inflammation in dogs with osteoarthritis.